Medical device and products maker Covidien said it has a definitive agreement to acquire CV Ingenuity, a privately held company focusing on treatments for peripheral arterial disease.
Covidien to acquire CV Ingenuity
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.
Recommended for You